v3.25.3
STOCKHOLDERS’ EQUITY - Narrative (Details)
$ in Millions
3 Months Ended 9 Months Ended
Oct. 01, 2025
member
shares
Sep. 30, 2025
USD ($)
shares
Sep. 30, 2024
USD ($)
Sep. 30, 2025
USD ($)
shares
Sep. 30, 2024
USD ($)
Jan. 09, 2024
shares
Restricted stock            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Shares available for future grant (in shares)   6,400,000   6,400,000    
Unrecognized compensation expense | $   $ 17.8   $ 17.8    
Restricted Stock Grants (2022 Plan) | Subsequent event            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Number of independent members | member 3          
Restricted Stock Grants (2022 Plan) | Restricted stock | Subsequent event            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted 19,157          
Restricted Stock Grants (2022 Plan) | Common Stock            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Shares reserved for issuance (in shares)   250,000   250,000    
CCPT IV 2018 Equity Incentive Plan | Restricted stock | General and Administrative Expenses            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Compensation expense | $   $ 2.5 $ 1.7 $ 6.3 $ 4.4  
CCPT IV 2018 Equity Incentive Plan | Common Stock            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Shares available for future grant (in shares)   61,000   61,000    
Restricted Stock Units (Manager Plan)            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Shares reserved for issuance (in shares)           12,000,000